Who Paid My Doc
Josephine Harrington
Advanced Heart Failure and Transplant Cardiology Aurora, CO Medical Doctor
NPI 1720442569 CMS profile 11620447
12605 E 16Th Ave, Aurora, CO 80045
General payments
$118,785
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Josephine Harrington of Aurora, CO is reported in the CMS Open Payments database as having received $118,785 across 44 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 88th percentile of Advanced Heart Failure and Transplant Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
2 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $101,592 | 40 | |
| 2024 | General | $17,192 | 4 |
Beside peers
- Josephine Harrington
- Advanced Heart Failure and Transplant Cardiology median
- Middle half of Advanced Heart Failure and Transplant Cardiology
- National median
In program year 2025, general payments to Josephine Harrington were reported at $101,592. Among 967 Advanced Heart Failure and Transplant Cardiology profiles paid that year, the median was $1,024 and the middle half received between $289 and $6,890.
Show as a table
| Year | Josephine Harrington | Advanced Heart Failure and Transplant Cardiology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $863 | $224–$4,562 | $163 |
| 2020 | $0 | $452 | $122–$3,992 | $114 |
| 2021 | $0 | $550 | $159–$3,571 | $132 |
| 2022 | $0 | $729 | $221–$4,357 | $149 |
| 2023 | $0 | $1,002 | $309–$5,827 | $160 |
| 2024 | $17,192 | $931 | $273–$5,204 | $164 |
| 2025 | $101,592 | $1,024 | $289–$6,890 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 6 drugsPart D claims
129
Drug cost
$68,439
Branded share of claims
68.2%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Ozempic Semaglutide | Brand | 43 | $37,454 | |
| Mounjaro Tirzepatide | Brand | 11 | $11,586 | |
| Jardiance Empagliflozin | Brand | 19 | $10,954 | |
| Entresto Sacubitril/Valsartan | Brand | 15 | $8,142 | |
| Rosuvastatin Calcium | Generic | 18 | $255 | |
| Amlodipine Besylate | Generic | 23 | $48 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 800 Part D prescribers listed as Advanced Heart Failure and Transplant Cardiology; they describe a distribution and say nothing about conduct.
Records
44 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Advanced Heart Failure and Transplant Cardiology in Colorado
Larry Allen
Advanced Heart Failure and Transplant Cardiology · Aurora, CO
William Cornwell
Advanced Heart Failure and Transplant Cardiology · Aurora, CO
Aaron Emmons
Advanced Heart Failure and Transplant Cardiology · Wheat Ridge, CO
Andreas Brieke
Advanced Heart Failure and Transplant Cardiology · Aurora, CO
Christine Sailer
Advanced Heart Failure and Transplant Cardiology · Aurora, CO
Amrut Ambardekar
Advanced Heart Failure and Transplant Cardiology · Aurora, CO
Related records
Advanced Heart Failure and Transplant Cardiology in Colorado
Practitioners in the same specialty and state, ranked by reported value.
All Advanced Heart Failure and Transplant Cardiology
Everyone recorded under this specialty, nationwide.
Doctors in Colorado
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.